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ABSTRACT 
Three-dimensional (3D) multicellular spheroids have been identified as a suitable model of solid 
tumours for drug screening and cancer research [1].  However, creating and monitoring a large 
number of spheroids using conventional methods remains labour-intensive.  This work reports a novel 
double-layer microfluidic device for the generation and culture of 3D multicellular spheroids and its 
use with biopsy samples.  The system enables drug concentration-response curves to be obtained from 
a limited amount of sample material by applying a drug concentration gradient using an integrated 
passive microchannel network.   
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INTRODUCTION 
The majority of drug screening assays currently carried out in research institutes and industry 
employs two-dimensional (2D) models mainly based on cell lines, which do not mimic the tumour 
microenvironment found in in vivo tumours.  3D multicellular spheroids have been identified as a 
more physiologically relevant model, yet their routine use in drug screening remains laborious.  A 
particular challenge is the screening of tumour biopsies which, due to the small number of cells 
contained in biopsies, imposes limitations on the number of compounds and concentrations to be 
tested.   
 
EXPERIMENTAL 
The device was fabricated using polydimethylsiloxane (PDMS) and consists of a bottom layer, 
which contains microwells for spheroid generation and culture, and a top layer with microchannels 
and inlets that enable cell seeding, medium exchange and drug application.  By dispensing pre-
determined volumes of drug solutions and medium into opposing inlet wells, a hydrostatic pressure 
gradient is created across the microwell chamber, which results in the formation of a stable drug 
concentration gradient for up to 10 hours.   
 
RESULTS AND DISCUSSION 
As initial validation, UVW cells, a high-grade glioma cell line, were used to form hundreds of 
spheroids per device (50-150 µm in diameter), achieving viable culture conditions for up to 21 days 
[2].  UVW spheroids were exposed to a range of cisplatin concentrations on day 5 of culture and 
monitored for a further 16 days.  Furthermore, a range of spheroid sizes can be generated in the 
device, which allows the evaluation of spheroid size-dependent effects of drugs on morphology and 
viability.  Spheroid viability was assessed with fluorescence microscopy by staining with propidium 
iodide (PI) and fluorescein diacetate (FDA) (Figure 1).  Using in-house developed software, areas and 
perimeters of all spheroids were determined from bright-field images.  This allowed the application of 
D SDUDPHWULF DQDO\VLV EDVHG RQ WKH VSKHURLG µVKDSH IDFWRU¶ WR TXDQWLI\ WKH H[WHQW RI GLVDJJUHJDWLRQ 
after drug treatment (Figure 2) [3].   
 
CONCLUSION 
This microfluidic design differs from existing solutions [4, 5] as it does not require active flow 
control for either cell injection or the creation of a drug concentration gradient.  Work is currently 
ongoing using cell suspensions from human prostate cancer biopsies to screen patient-derived 
spheroids using the proposed microfluidic system.  Overall, this device presents an invaluable tool for 
personalised medicine and cancer research when only a small amount of patient material is available.   
 Figure 1: Representative images within the array of viable cells, stained green (FDA), and dead cells, 
stained red (PI), 3 days after cisplatin administration.  Scale EDUVDUHȝP.   
 
Figure 2: Dose response curves (data points and interpolation) quantifying spheroid disaggregation 
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DQG
medium-VL]HGȝPGLDPHWHUVSKHURLGVDQGUHVSHFWLYH(&VGUXJFRQFHQWUDWLRQWKDWSURGXFHV
a half-maximal response).   
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